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Cloning and expression 
Plasmid A containing the coding sequence of MptpA was kindly provided by Dr. Anil 
Koul. The plasmid war used as template and the phosphatase gene was amplified by 
PCR and cloned into the NdeI/BamHO site of pET16bTev, which is a modified 
version of the pET16b (Novagen, Madison, WI, USA) expression vector where the  
Factor Xa-cleavage site has been replaced by a tobacco etch virus (Tev) protease 
cleavage site. The resulting expression plasmid pET PtpA was used for trans-
formation of E. coli strain B121 (DE3) (Novagen). The construct was verified by 
sequencing. 
Cells were grown in the presence of 100 µg/mL ampicillin at 25 °C unti the OD600 
reached 0.6 and then recombinant protein production was initiated by adding 1 mM 
 2 
IPTG (isopropyl-b-D-thiogalactopyranoside). After 4 hours induction, cells were 
harvested and stored at -80 °C until usage. 
 
Purification of the phosphatase  
Cell pellets were thawed and resuspended in 25 mM Hepes pH 8.0, 200 mM NaCl,  
10 mM b-mercaptoethanol. 2 mg lysozyme and 100 U benzonase (Merck, Darmstadt, 
Germany) were added per mL of the protein suspension. Cells were lyzed by 
sonification and the cell debris was removed by centrifugation at 20000 g for 20 min 
at 4 °C. The supernatant was applied to a Ni-NTA FastFlow column (Quiagen, 
Hilden, Germany) following the manufacturers’ recommendations. Further purification 
was achieved by gelfiltration chromatography with a Hi Load 26/60 Superdex 75 
column (Pharmacia Biotech) equilibrated in 25 mM Hepes pH 7.4, 200 mM NacCl, 10 
mM DTT, 5 % glycerol. 
